28/10/2024
Congratulations to Dr Nick Everett, with Psylo, Tessara Therapeutics awarded $3 million CRC-P grant to develop novel neuroplastogens for the treatment of substance use disorders!
Dr Everett of the Translational Psychopharmacology research team focuses on substance use disorders.
This newly funded research has the potential to not only develop a novel pharmacotherapy for addictions by targeting neural and cognitive processes which are often overlooked as therapeutic targets (Psylo), but also to transform the pre-clinical development pipeline for novel addiction therapeutics to bring much-needed scale, efficiency, and validity to this underfunded and slow-moving field (Tessara Therapeutics).
Australian government (Cooperative Research Centres) CRC-P grant will enable the research into substance use disorder to continue.
Read ➡️ https://bit.ly/CRCPGrant3MNickEverett
Translational Psychopharmacology research team ➡️ https://bit.ly/TransPsychopharmacology
Faculty of Science, University of Sydney University of Sydney